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ABSTRACT 
DNA and chromosomal damage in peripheral blood leukocytes of patients with coronary ar-
tery disease (CAD) were investigated by using the single cell gel electrophoresis assay /comet 
and cytokinesis- block micronucleus (CBMN) assays, respectively. The case-control study 
comprised patients with CAD (n = 46; average age 53.0 ± 1.27 y) undergoing treatment at lo-
cal hospitals, and healthy age-and sex-matched controls (n = 19; average age 54.21 ± 0.91 y) 
from the general population. The results of the comet assay revealed that the mean values of 
DNA damage were significantly (p < 0.001) higher in CAD patients than in controls (Tail 
DNA% 11.55 ± 0.38 vs. 5.31 ± 0.44; Tail moment 6.17 ± 0.31 vs. 2.93 ± 0.21 AU; Olive tail 
moment 3.52 ± 0.23 vs. 1.25 ± 0.11 AU). The mean values of chromosomal damage were also 
significantly higher (p < 0.001) in CAD patients than in controls (Binucleated cells with MN- 
28.15 ± 1.18 vs. 18.16 ± 2.59; micronuclei 29.52 ± 1.21 vs. 18.68 ± 2.64, respectively) while 
nuclear division index (1.48 ± 0.01 vs. 1.63 ± 0.01) was significantly higher (p < 0.001) in 
controls. The results of the present study indicate that coronary artery disease patients had in-
creased levels of both, unrepaired (DNA) and repaired (chromosomal) genetic damage which 
may be a pathological consequence of the disease and/or the drug-treatment. This accumula-
tion of DNA/chromosomal damage is of concern as it can lead to the development of cancer 
with increased chances of morbidity and mortality in the CAD patients.  
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INTRODUCTION 
Coronary artery disease (CAD) is one of 
the most common causes of death and disa-
bility worldwide (Zaman et al., 2000). Ge-
netic predisposition and interaction with a 
host of environmental (endogenous and ex-
ogenous) factors can cause the disease. 
Among the risk factors predisposing to 
CAD are hypertension, obesity, hyperlipi-
demia, stress, smoking, age, gender and fa-
mily history (Kasap et al., 2007). Oxidative 
stress has also emerged as a major risk fac-
tor (Yung et al., 2006) in CAD arising 
through an imbalance between oxidants and 
antioxidants (Nojiri et al., 2001). The oxi-
dative modification of low density lipopro-
teins (LDL) also plays a causative role in 
the pathogenesis of coronary artery disease 
(Chisolm and Steinberg, 2000). Further-
more, consequences of oxidative stress can 
cause damage to genomic integrity as ath-
erosclerotic plaques have been reported to 
exhibit extensive genetic damage (Martinet 
et al., 2002). In fact, reports have also docu-
mented the contribution of DNA damage to 
the development and progression of coro-
nary artery disease (Andreassi, 2003). 
There has been an increase in heart dis-
ease in Punjabi population which may be 
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attributed to economic surplus and change 
in dietary and life-style patterns (Anony-
mous, 2013). The changeover from exten-
sive agrarian activities to a sedentary / near 
sedentary life-style and the adaptation of 
the western dietary habits across the lower, 
upper middle and upper socioeconomic sta-
tus classes, have resulted in increased gen-
eral and abdominal obesity (WHO, 2003). 
As no studies have come to attention in 
Punjabi populations associating CAD with 
genomic damage, in the present study, 
adults (CAD patients and healthy controls) 
have been assessed for chromosomal and 
DNA damage in their peripheral blood leu-
kocytes (PBL). Correlation of genomic 
damage has further been studied with vari-
ous risk factors viz. lipid profile, hyperten-
sion, diabetes, obesity parameters (body 
mass index, waist-hip ratio, waist circum-
ference) and oxidative stress (lipid peroxi-
dation, total oxidant status, total antioxidant 
capacity, oxidative stress index). 
For genetic damage assessment, chro-
mosomal damage in peripheral blood lym-
phocytes using the Cytokinesis-Block mi-
cronucleus (CBMN) assay and DNA dam-
age in PBL using the single cell gel electro-
phoresis (SCGE/comet) assay have been 
carried out. The CBMN assay is a well 
known cytogenetic test-method to assess 
the genetic effects of spontaneously and 
mutagenically- induced DNA damage 
(Fenech, 2007) and the comet assay is a 
sensitive biomarker of oxidative stress and 
DNA damage (Balasubramanyam et al., 
2010). 
 
MATERIALS AND METHODS 
Subjects 
The study proposal was approved by the 
Institutional Ethics Committee and volun-
tary written informed consent was taken 
from all study participants (n = 65). Patients 
with diagnosed CAD were contacted from 
local hospitals through the cardiologists. 
Exclusion criteria included CAD patients 
with renal, liver or thyroid disorders, those 
with negative results on the treadmill test, 
and those not belonging to the Punjabi pop-
ulation. The control group included healthy 
adults with no past or present history of 
heart or any disease and no exposure histo-
ry, matched for gender, population group 
and socioeconomic status. 
 
Data and sample collection 
The demographic and disease-related 
information for each patient was document-
ed on a pre-designed questionnaire. Anthro-
pometric measurements (height, weight, hip 
circumference, waist circumference) were 
taken following standard methodology 
(Weiner and Lourie, 1981). Derived obesity 
measures were Body Mass Index (BMI) 
and Waist Hip Ratio (WHR). Using the cri-
teria of WHO (2004) for BMI, the partici-
pants were classified as obese or non-obese 
regarding general obesity, and cut-offs as 
per Snehalatha et al. (2003) for WHR and 
waist circumference (WC) values for ab-
dominal obesity. Physiometric measure-
ments (using a mercury sphygmomanome-
ter and stethoscope) were taken after the 
subject had rested for ten minutes as per the 
recommendations of American Heart Asso-
ciation (Kirkendall et al., 1981). The aver-
age of three measurements were taken as 
the blood pressure values. The mean arterial 
blood pressure (MBP) was calculated from 
systolic and diastolic measurements (Pé-
russe et al., 1989). Venous blood (5 ml) was 
then drawn from each participant and pro-
cessed for the CBMN and SCGE assays. 
The Cytokinesis-Block Micronucleus 
(CBMN) assay: - Short term lymphocyte 
cultures were set up (Moorhead et al., 1960) 
and the CBMN protocol of Fenech (2000) 
was followed. Briefly, the leukocyte-rich 
plasma (2 ml) was added to 8 ml of RPMI 
1640 medium (HiMedia, India). The lym-
phocytes were stimulated to divide by addi-
tion of Phytohaemagglutinin-M (0.5 µg/ml 
PHA-M, Biological Industries, Israel). The 
cultures were incubated for 72 h at 37 °C; 
after 44 h cytokinesis was blocked by the 
addition of cytochalasin-B (6 µg/ml, Sig-
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ma) and on completion of incubation of 
72 h at 37 °C, the cultures were harvested. 
Following centrifugation (800 g, 10 min), 
the pellet was fixed in chilled fixative 
(3 methanol: 1 glacial acetic acid, Quali-
gens, India and SRL, India, respectively) 
for 30 min. After centrifugation and two-
three washings of the pellet, the cell sus-
pension was used to prepare the slides. The 
air-dried slide preparations were stained 
with 5 % Giemsa (HiMedia, India) for 10-
20 minutes. For each sample, two slides 
were prepared and coded. A total of 2000 
binucleated cells (1000/slide) were scored 
for the presence of micronuclei (MN) and 
micronucleated cells following the criteria 
of Fenech (2007). Random observations by 
another scorer were done to verify the ob-
servations. The Nuclear Division Index 
(NDI), which is an index of cytostatic ef-
fects, was calculated (Eastmond and Tuck-
er, 1989) by using the formula: 
NDI = (M1+2M2+3M3+4M4)/N  
where M1-M4 represent the number of cells 
with 1-4 nuclei and N is the total number of 
cells scored.. 
The SCGE/Comet assay: The Trypan-
Blue Dye Exclusion test for cell viability 
was performed (Strober, 2001) and samples 
with > 95 % cell viability were processed 
for the comet assay. 
The leukocytic DNA damage was ascer-
tained using the alkaline comet assay 
(Singh et al., 1998). In brief, on pre-coated 
slides with 1 % normal melting point aga-
rose (NMPA; SRL, India), a second layer 
containing 30 µl of blood sample mixed 
with 110 µl of 5 % low melting point aga-
rose (LMPA, SRL, India) was poured fol-
lowed by the sandwiching with a third layer 
of 120 µl of 5 % LMPA after the second 
layer had set. Cells were lysed in freshly 
prepared cold lysing solution (2.5 M NaCl, 
100 mM Na2 EDTA, 10 mM Tris Hcl, pH 
10.0; 1 % Triton X-100 with 10 % DMSO 
added just before use) for at least one hour 
to allow DNA unfolding. Then the slides 
were placed in a horizontal electrophoresis 
chamber, covered with freshly prepared al-
kaline electrophoresis buffer (0.3 M NaOH, 
1 mM NO2 EDTA, pH > 13) at 4 °C for 
unwinding and expression of alkali-labile 
sites (30 min) and subsequently electro-
phoresed (25V, 300mA, 0.7-1.0 -v/cm, 25 
min). Slide preparations were then washed 
with neutralizing buffer (0.4 M Tris HCl 
pH 7.5) to remove alkali and detergents, 
and left for drying. The slides were silver 
stained (Nadin et al., 2001) and coded. 
Scoring was done using the freely available 
CASP (Comet Assay Software Programme, 
3.1.2 version). For this, images were cap-
tured with an Olympus camera (E420, To-
kyo, Japan) fitted on an Olympus micro-
scope (CX41, Tokyo, Japan). A total of 100 
cells per sample were scored for per cent 
tail DNA, Tail Moment and Olive Tail 
Moment as indices of DNA damage. 
 
Statistical analysis 
Statistical analysis was performed using 
the Statistical Package for the Social Sci-
ences (SPSS, version 16.0 for Windows 7). 
The results on various observations are ex-
pressed as mean ± S.E.M. The data showed 
normal distribution and therefore paramet-
ric tests were performed. Differences be-
tween controls and patients for genetic 
damage indices were analyzed by the Stu-
dent’s t-test. Demographic variables of pa-
tients and control groups were analyzed us-
ing the Chi-square test. The association be-
tween DNA/chromosomal damage and oth-
er variables was assessed by the Pearson’s 
correlation test. The independence of these 
associations was tested by multiple linear 
regression analysis. For all calculations, the 
level of significance was taken as p < 0.05. 
 
RESULTS 
The demographic and clinical character-
istics of patients and controls are presented 
in Table 1. CAD patients had been diag-
nosed by the cardiologists on the basis of 
clinical symptoms, ECG findings, treadmill 
test and echocardiography. There were 26 
males (mean age 49.62 ± 1.73 y) and 20 
females (mean age 57.30 ± 1.31 y) in the 
EXCLI Journal 2013;12:872-884 – ISSN 1611-2156 
Received: August 08, 2013, accepted: September 12, 2013, published: October 08, 2013 
 
 
875 
Table 1: Baseline and clinical characteristics of patients and controls 
Variables Range Patients n (%) 
Controls 
n (%) 
chi-square-
value 
p-
value 
Age (years) 30 - 48 11 (23.9) 3 (15.8) 0.154 0.69449 - 67 35 (76.1) 16 (84.2)
Gender Male 26 (56.5) 13 (68.4) 0.375 0.540Female 20 (43.5) 6 (31.6)
BMI (kg/m2)a 
Underweight 1 (2.2) 0
13.499 0.004Normal 13 (28.3) 14 (73.7)Overweight 18 (39.1) 5 (26.3)
Obese 14 (30.4) 0
Waist circumference 
(cm)b 
Men < 0.85 3 9 12.755 0.000≥ 0.85 23 4
Women < 0.80 1 0 0.425 0.546≥ 0.80 19 6
WHRb 
Men 
 
< 0.89 0 1 0.128 0.720≥ 0.89 26 12
Women 
 
< 0.81 0 0 6.500 0.011≥ 0.81 20 6
Socioeconomic  
statusc 
Upper 7 (15.2) 3 (15.8)
0.061 0.970Upper middle 35 (76.1) 14 (73.7)
Lower middle 4 (8.7) 2 (10.5)
Physical activity 
 
Sedentary 33 (71.7) 7 (36.8) 5.522 0.019Moderate 13 (28.3) 12 (63.2)
Diet 
 
Vegetarian 19 (41.3) 9 (47.4) 0.030 0.862Non-vegetarian 27 (58.7) 10 (52.6)
Alcohol drinking 
 
Yes 24 (52.2) 6 (31.6) 1.514 0.214No 22 (47.8) 13 (68.4)
Diabetes mellitus 
 
Yes 13 (28.3) 0 5.062 0.024No 33 (71.7) 19 (100.0)
Blood pressure 
(mmHg)d 
Normal <120/ < 80 2 (4.3) 8 (42.1)
24.260 0.000
Pre-
Hyperten-
sive 
120-139 / 
80-89 18 (39.1) 11 (57.9)
Stage-I-
Hyperten-
sive 
140-159 / 
90-99 17 (37.0) 0
Stage-II-
Hyperten-
sive 
≥160 / 
≥100 9 (19.6) 0
Medication 
Aspirin  
(Anti-inflammatory) 
Yes 31 (67.4) 0 21.852 0.000No 15 (32.6) 19 (100.0)
Lasix (Diuretic) Yes 27 (58.7) 0 16.736 0.000No 19 (41.3) 19 (100.0)
Metoprolol  
(Beta-blocker) 
Yes 24 (52.2) 0 13.555 0.000No 22 (47.8) 19 (100.0)
Ramipril  
(ACE-inhibitor) 
Yes 22 (47.8) 0 11.683 0.000No 24 (52.2) 19 (100.0)
BMI: body mass index; WC: waist circumference; WHR: waist hip ratio, aWHO (2004), bSnehalatha et al. (2003),  
cKumar et al. (2007), dJNC 7 report (Chobanian et al., 2003) 
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patient group. The control group included 
13 males (mean age 53.54 ± 1.17 y) and 6 
females (mean age 55.67 ± 1.33 y). On the 
basis of BMI, there were 14 obese patients 
(BMI ≥ 25.0 kg/m2) while the WHR re-
vealed that 26 male and 20 female patients 
were obese as per the cut-off values given 
by Snehalatha et al. (2003). On the basis of 
the waist circumference cut-offs (Snehala-
tha et al., 2003), 23 male (> 85cm) and 19 
female (> 80cm) patients had abdominal 
obesity. Alcohol drinking was observed in 
52.20 % male patients and in 31.60 % male 
healthy controls. There were 28.30 % pa-
tients with diabetes mellitus and 56.50 % 
with hypertension. Non-vegetarian diet was 
preferred by 58.70 % of the patients and 
52.60 % of the controls and sedentary life 
style was observed by 71.70 % CAD pa-
tients and only by 36.80 % of controls. Re-
garding medication in the patients group, 
67.40 % were taking Aspirin (anti-inflam-
matory), 58.70 % Lasix (diuretic), 52.20 % 
Metoprolol (beta-blocker) and 47.80 % 
were taking Ramipril (ACE-inhibitor). So-
cioeconomic status (SES) was inferred ac-
cording to the criteria given by Kumar et al. 
(2007). There were almost equal percentage 
of patients (15.20 %) and controls 
(15.80 %) belonging to upper SES. Similar-
ly, 76.10 % patients and 13.70 % controls 
belonged to upper-middle SES, while 
8.70 % among patients and 10.50 % among 
controls had lower-middle SES. Informa-
tion about the history of disease revealed 
that date-of-onset/diagnosis ranged from 
35-72 y (average 53.09 ± 1.3 y) and the pa-
tients were on medication from 1-15 y (av-
erage 5.04 ± 0.6 y). 
On Chi-square analysis it was observed 
that the demographic variables of patients 
and controls matched for age, gender, alco-
hol drinking, diet preference, socioeconom-
ic status, WHR (men) and waist circumfer-
ence (women), while BMI, diabetes, dysli-
pidemia, physical activity, WHR (women), 
waist circumference (Men), blood pressure, 
MBP and medication showed differences 
being characteristic of patients. In Table 2, 
the information on genetic damage indices 
in patients and controls is presented. The 
Trypan-Blue Dye Exclusion test had re-
vealed 95.60 - 99.80 % cell viability of all 
samples. The comet parameters used as 
metrics of DNA damage were Tail moment 
(TM = Tail DNA% × tail length in arbitrary 
units, AU), Tail DNA% (TD = amount of 
DNA in comet tail in percentage) and Olive 
Tail Moment (OTM = tail mean-head mean 
× % DNA in tail in AU). A comparison be-
tween patients and controls for these DNA 
damage indices revealed that the values 
were significantly (p < 0.001) higher in pa-
tients compared to those in controls. How-
ever no gender differences for these values 
were observed among patients and hence 
the respective data were pooled for genders 
in both, the control and patient groups. Sep-
arate analysis also showed highly signifi-
cant differences (p < 0.001) for both, male 
and female patients from their control coun-
terparts for DNA damage indices. 
For the assessment of chromosomal da-
mage, the binucleated cells with micronu-
clei (BNMN), number of micronuclei in bi-
nucleated cells (MN) and the nuclear divi-
sion index (NDI) were studied. Statistical 
analysis revealed that the BNMN and MN 
values were significantly (p < 0.001) higher 
and NDI values lower in patients than in 
controls. As observed for DNA damage, no 
gender differences for chromosomal dam-
age were observed among patients and con-
trols, though values in male and female pa-
tients for BNMN and MN were significant-
ly higher (p < 0.001) in patients while NDI 
values were significantly (p < 0.001) higher 
in controls. On correlation and association 
analyses (Table 3), significant positive cor-
relation (correlation coefficient = r) was ob-
served between BNMN and diabetes melli-
tus (r = 0.297, p = 0.045) and between NDI 
and MDA levels (r = 0.296, p = 0.045) and 
with age (r = 0.571, p = 0.000). Positive 
correlation was observed between tail 
DNA % and diabetes mellitus (r = 0.442, 
p = 0.004) and with WHR (r = 0.349, 
p = 0.017) and between tail moment and  
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Table 2: DNA and chromosomal damage in the patient and control groups 
Study group 
DNA damage  
(SCGE assay) Mean ± S.E.M 
Chromosomal damage  
(CBMN assay)Mean ± S.E.M 
Tail  
DNA % 
Tail  
Moment 
(AU) 
Olive Tail 
Moment 
(AU) 
BN cells 
with MN MN NDI 
Patients 
vs. con-
trols total 
Patients 11.55 ± 0.38 6.17 ± 0.30 1.25 ± 0.11 28.15 ± 1.18 29.52 ± 1.21 1.48 ± 0.01 
Controls 5.31 ± 0.44 2.39 ± 0.21 1.25 ± 0.11 18.16 ± 2.59 18.68 ± 2.64 1.63 ± 0.01 
p-value 0.000 0.000 0.000 0.001 0.001 0.000 
Male vs. 
female  
patients 
Male 11.15 ± 0.43 6.33 ± 0.43 3.68 ± 0.37 27.81 ± 1.39 29.31 ± 1.42 1.45 ± 0.02 
Female 12.07 ± 0.67 5.97 ± 0.44 3.31 ± 0.21 28.60 ± 2.07 29.8 ± 2.11 1.51 ± 0.02 
p-value 0.238 0.569 0.423 0.744 0.842 0.076 
Male vs. 
female 
controls 
Male 5.38 ± 0.53 2.45 ± 0.26 1.32 ± 0.15 15.62 ± 2.60 16.23 ± 2.67 1.62 ± 0.01 
Female 5.15 ± 0.88 2.25 ± 0.39 1.11 ± 0.14 23.67 ± 5.71 24 ± 5.85 1.65 ± 0.02 
p-value 0.816 0.673 0.417 0.154 0.179 0.275 
Patient vs. 
control 
males 
Patients 11.15 ± 0.43 6.33 ± 0.42 3.68 ± 0.37 27.81 ± 1.39 29.31 ± 1.42 1.45 ± 0.02 
Controls 5.38 ± 0.53 2.45 ± 0.26 1.32 ± 0.15 15.62 ± 2.60 16.23 ± 2.67 1.62 ± 0.01 
p-value 0.000 0.000 0.000 0.000 0.000 0.000 
Patient vs. 
control 
females 
Patients 12.07 ± 0.67 5.97 ± 0.44 3.31 ± 0.21 28.60 ± 2.07 29.80 ± .11 1.51 ± 0.02 
Controls 5.15 ± 0.88 2.25 ± 0.39 1.11 ± 0.14 23.67 ± 5.71 24 ± 5.85 1.65 ± 0.02 
p-value 0.000 0.000 0.000 0.320 0.254 0.000 
BN: binucleated cells; MN: micronuclei; NDI: nuclear division index; AU: arbitrary units 
Values in bold are significant (p < 0.05; Student’s t-test) 
 
 
Table 3: Bivariate correlation analysis of DNA and chromosomal damage parameters with  
demographic and clinical factors 
Variables 
Tail DNA% Tail moment Olive Tail Moment BN with MN MN NDI 
r p r p r p r p r p r p 
Age -0.161 0.284 0.312 0.035 -0.178 0.238 -0.183 0.225 -0.167 0.267 0.571 0.000 
BMI -0.115 0.447 -0.085 0.575 -0.091 0.548 -0.106 0.481 -0.093 0.541 -0.167 0.268 
WC 0.079 0.603 -0.260 0.081 -0.096 0.526 -0.067 0.660 -0.083 0.585 0.128 0.396 
WHR 0.349 0.017 -0.022 0.885 0.213 0.155 0.112 0.460 0.073 0.628 0.098 0.515 
Hyper-
tension -0.085 0.574 -0.136 0.366 0.159 0.292 -0.153 0.309 -0.142 0.345 0.209 0.164 
Diabetes 0.442 0.004 0.009 0.954 0.009 0.955 0.297 0.045 0.273 0.066 0.045 0.769 
Alcohol 
drinking -0.174 0.249 0.233 0.120 0.005 0.972 0.228 0.128 0.256 0.086 -0.068 0.654 
TC 0.149 0.323 -0.048 0.749 0.174 0.247 0.040 0.791 0.046 0.763 0.046 0.763 
HDL-C 0.322 0.029 -0.028 0.854 0.149 0.324 -0.002 0.991 -0.010 0.949 -0.096 0.526 
TG 0.109 0.472 -0.004 0.980 -0.121 0.422 -0.078 0.606 -0.072 0.635 -0.041 0.788 
LDL 0.002 0.989 -0.035 0.818 0.104 0.493 0.040 0.792 0.049 0.747 0.087 0.565 
MDA 0.254 0.088 -0.230 0.124 -0.129 0.394 -0.227 0.130 -0.207 0.169 0.296 0.046 
TAS 0.040 0.789 0.048 0.753 0.254 0.089 0.111 0.461 0.108 0.475 -0.127 0.399 
TOS 0.222 0.138 0.015 0.922 0.226 0.132 0.005 0.975 0.029 0.848 0.180 0.231 
OSI 0.247 0.098 0.048 0.751 0.087 0.566 -0.116 0.444 -0.110 0.647 0.261 0.080 
BN with MN: binucleated cells with micronuclei; MN: micronuclei; NDI: nuclear division index; BMI: body mass index; WC: waist 
circumference; WHR: waist hip ratio; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; TG: triglycerides; LDL: 
low density lipoproteins; MDA: malondialdehyde; TAS: total antioxidant status; TOS: total oxidant status; OSI: oxidative stress 
index; r: correlation coefficient; p: p-value.Values in bold are significant (p < 0.05). 
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age (r = 0.312, p = 0.035). On multiple lin-
ear regression analysis (Table 4), regression 
coefficient (B) values for age (B = 0.076, 
p = 0.035), WHR (B = 25.859, p = 0.018) 
and diabetes mellitus (B = 2.251, p = 0.004) 
were observed to be independent predictors 
for DNA damage and NDI for chromoso-
mal damage (B = 0.007, p = 0.001). In or-
der to discern if there was any association 
between DNA damage and chromosomal 
damage parameters, correlation analysis 
was carried out but it revealed no signifi-
cant associations (Table 5). 
As oxidative stress and lipid profile bi-
omarkers of this study group had earlier 
been reported to be significantly higher 
among the patients (Bhat et al., 2012), it 
was also thought appropriate to ascertain 
whether there was any correlation (Table 3) 
and/or association (Table 4) of these varia-
bles with genetic damage. Correlation and 
regression analyses were hence performed 
for genetic damage (DNA/chromosomal 
damage) with oxidative stress parameters of 
malondialdehyde (MDA), total oxidant sta-
tus (TOS), total antioxidant status (TAS) 
and oxidative stress index (OSI) and also 
with lipid profile biomarkers (total choles-
terol, High density lipoprotein cholesterol 
(HDL-C), Triglycerides, very low density 
lipoprotein (VLDL) and low density lipo-
protein (LDL). These showed neither corre-
lation nor association with genetic damage 
except HDL-C and MDA levels which 
showed positive correlation (r = 0.322, 
p = 0.029; r = 0.296, p = 0.046 respective-
ly) and regression (B = 0.259, p = 0.029; 
B = 0.013, p = 0.046 respectively) with per 
cent tail DNA and NDI respectively.  
 
DISCUSSION 
It has often been reported that genetic 
damage may be caused by both, extrinsic 
and intrinsic environments (Gray and Ben-
nett, 2011). The DNA damage can manifest 
as DNA strand-breaks, alkali-labile sites, 
incomplete repair sites and cross-links 
while chromosomal damage appears as 
chromosomal aberrations (gaps, breaks, 
translocations, rings, insertions) as well as 
micronuclei (MN). MN originate from 
chromosome fragments or whole chromo-
somes that are not included in the main 
daughter nuclei during nuclear division 
(Fenech, 2000). In the present study, the 
SCGE assay was used to measure the level 
of DNA damage (unrepaired) and the 
CBMN assay to measure the level of chro-
mosomal damage (repaired) in patients and 
controls. The results from the comet assay 
demonstrated that patients diagnosed with 
CAD had higher values of percentage of tail 
DNA (2.1x), Tail moment (3 x) and Olive 
tail moment (3 x), indicative of higher 
DNA damage in peripheral blood leuko-
cytes of CAD patients than the normal con-
trols. There were no gender differences for 
these indices on statistical analysis imply-
ing that in this study group, genetic damage 
levels (both DNA and chromosomal) are 
similar in males and females among pa-
tients and controls. 
The results of the present study have 
shown significant increase in unrepaired 
and repairable genetic damage in peripheral 
blood leukocytes/lymphocytes of patients 
with coronary artery disease. Reports in lit-
erature have implicated excessive oxidative 
stress and inadequate defenses in the patho-
genesis of cardiovascular disease (Andreas-
si, 2003) besides genetic damage in athero-
sclerotic plaques (Martinet et al., 2002). As 
oxidative stress has been implicated as a 
major contributor in the progression of ath-
erosclerosis (Norman et al., 2001), it could 
also be a causative factor for DNA damage 
in coronary artery disease as DNA damage 
occurs frequently in cells exposed to reac-
tive oxygen species (Botto et al., 2001). 
The CAD patients of the present study also 
had significantly increased (3 folds) oxida-
tive stress as given in an earlier work (Bhat 
et al., 2012). This oxidative stress hence 
could be contributing to the observed DNA 
and chromosomal damage in CAD patients. 
As dyslipidemia is an important causative 
factor for coronary artery disease (Arca et 
al., 2007), the patients of the present study  
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Table 4: Univariate and multivariate regression analyses: DNA and chromosomal damage with demographic and clinical factors 
Damage 
parameters 
Variables 
  Age BMI WC WHR HNT DM Alcohol TC HDL TG LDL MDA TOS TAS OSI 
Univariate Regression Analysis 
Tail DNA % B -0.049 -0.083 0.061 27.968 -0.464 2.394 -0.888 0.054 0.259 0.026 0.001 0.276 0.031 0.023 0.200 p 0.284 0.447 0.603 0.017 0.574 0.004 0.249 0.323 0.029 0.427 0.989 0.088 0.789 0.138 0.098 
TM B -0.076 -0.049 -0.162 -1.402 -0.594 0.039 0.951 -0.014 -0.018 0.000 -0.010 -0.199 0.030 0.001 0.031 p 0.035 0.575 0.081 0.885 0.366 0.954 0.120 0.749 0.854 0.980 0.818 0.124 0.753 0.922 0.752 
OTM B -0.032 -0.039 -0.045 10.251 0.519 0.009 0.016 0.038 0.072 -0.017 0.022 -0.084 0.118 0.014 0.042 p 0.038 0.548 0.526 0.155 0.292 0.955 0.972 0.247 0.324 0.422 0.493 0.394 0.089 0.132 0.566 
BNMN B -0.172 -0.240 -0.162 27.812 -2.600 5.252 3.629 0.046 -0.004 -0.057 0.044 -0.764 0.269 0.002 -0.291 p 0.225 0.481 0.660 0.460 0.309 0.045 0.128 0.791 0.991 0.606 0.720 0.130 0.461 0.975 0.444 
MN B -0.160 -0.212 -0.204 18.590 -2.456 4.909 4.140 0.053 -0.024 -0.054 0.055 -0.708 0.265 0.009 -0.282 p 0.267 0.514 0.585 0.628 0.345 0.066 0.086 0.763 0.949 0.635 0.747 0.169 0.475 0.848 0.467 
NDI B 0.007 -0.005 0.004 -0.320 0.046 0.010 -0.014 0.001 -0.003 0.000 0.001 0.013 -0.004 0.001 0.009 p 0.000 0.268 0.396 0.515 0.164 0.768 0.654 0.763 0.526 0.788 0.565 0.046 0.399 0.231 0.080 
  Multivariate Regression Analysis 
Tail DNA % B - - - 25.859 - 2.251 - - 0.119 - - - - - - p - - - 0.018 - 0.004 - - 0.279 - - - - - - 
TM B -0.076 - - - - - - - - - - - - - - p 0.035 - - - - - - - - - - - - - - 
OTM B - - - - - - - - - - - - - - - p - - - - - - - - - - - - - - - 
BNMN B - - - - - - - - - - - - - - - p - - - - - - - - - - - - - - - 
MN B - - - - - - - - - - - - - - - p - - - - - - - - - - - - - - - 
NDI B 0.007 - - - - - - - - - - 0.000 - - - p 0000 - - - - - - - - - - 0.948 - - - 
BMI: body mass index; WC: waist circumference; WHR: waist hip ratio; HNT: hypertension; DM: diabetes mellitus; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; TG: triglycerides; 
LDL: low density lipoproteins; MDA: malondialdehyde; TOS: total oxidant status; TAS: total antioxidant status; OSI: oxidative stress index; TM: tail moment; OTM: Olive tail moment; BNMN: binucle-
ated cells with micronuclei; MN: micronucleated cells; NDI: nuclear division index; B: regression coefficient; p: p-value. Values in bold are significant (p < 0.05). 
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Table 5: Bivariate correlation analysis: DNA damage versus chromosomal damage 
Variables 
Tail DNA% Tail moment OTM 
r p r p r p 
BN with MN 0.176 0.241 0.193 0.199 0.192 0.202 
MN 0.166 0.272 0.196 0.192 0.200 0.182 
NDI -0.231 0.122 -0.066 0.662 -0.062 0.684 
r: correlation coefficient; OTM: Olive tail moment; BN with MN: binucleated cells with MN; MN: micronuclei; NDI: nuclear division 
index. Significant levels p < 0.05 
 
had earlier been assessed for their lipid pro-
file and had higher levels of triglycerides 
and total cholesterol and low levels of high 
density lipoprotein-cholesterol despite treat-
ment (Bhat et al., 2012). The HDL-C and 
MDA levels showed positive correlation 
with genetic damage on correlation and re-
gression analyses implying that dyslipidem-
ia also induced oxidative stress (higher 
MDA levels) and could also be contributing 
to the observed genetic damage in these pa-
tients. 
In literature, various studies have de-
monstrated increased genetic damage in pa-
tients with heart disease. Increased produc-
tion of oxidant free radicals was observed 
in patients with ischemic heart disease 
(Logacheva et al., 2001) and with evidence 
of oxidative DNA damage in cells within 
the atherosclerotic plaque (Mahmoudi et al., 
2006) implying that genomic damage may 
itself be inducing CAD. In their study on 
Indian CAD patients, Rajesh et al. (2011) 
reported increased DNA damage (per cent 
tail DNA) while Botto et al. (2001) had also 
reported increased DNA damage levels in 
patients with coronary artery disease. 
Demirbag et al. (2005) had also document-
ed that DNA strands breaks, oxidized py-
rimidines and altered purines were signifi-
cantly higher in leukocytes of CAD pa-
tients. 
The Cytokinesis block micronucleus as-
say was used for chromosomal damage as-
sessment. The key advantage of the MN as-
say lies in its ability to detect both, clasto-
genic and aneugenic events, and to identify 
cells which have divided once in culture 
(Fenech, 2002). The results of the present 
study showed that BNMN (1.5 fold) and 
MN (1.6 fold) values were significant in-
creased in patients while NDI (a biomarker 
of cytotoxicity) was significantly higher in 
controls (p < 0.001) than in patients imply-
ing that the cell proliferation was reduced 
while genomic damage was elevated in pa-
tients. There is similarity of these results 
with those of Ramakrishnan et al. (2011) 
who have also documented increased MN 
levels among Indian CAD patients. Increase 
in BNMN among CAD patients in an Ital-
ian population had also been earlier report-
ed (Andreassi et al., 2005). The results of 
the present study are also supported by 
those of Botto et al. (2001) who had ob-
served approximately 5.6 folds increase in 
MN levels in CAD patients while Andreassi 
et al. (2005) had reported 3.1 folds increase 
in MN frequency in CAD patients. 
The observed DNA damage in patients 
of the present study could also have been 
contributed by the action of the medications 
prescribed to these patients namely, Asprin 
(anti-inflammatory), Lasix/Furosemide 
(Diuretic), Metoprolol (beta-blocker) and 
Ramipril (Ace-inhibitors). Studies on geno-
toxicity of Asprin have shown positive ef-
fects in Bacillus subtilis assay (Kawachi et 
al., 1980) and invitro in the Chinese ham-
ster lung cells (Ishidate, 1983) though nega-
tive effects have also been reported in the 
Ames test (McCann et al., 1975) and in the 
Chinese hamster ovary cells (Stich et al., 
1981). Recent study on Furosemide by 
Mondal et al. (2012) has reported DNA 
strand breaks in mice hepatocytes detected 
by comet assay. Chromosomal aberrations 
in Chinese hamster ovary and lung fibro-
blast cells and in mouse germ cells have al-
so been reported (Jameela et al., 1979; 
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Bucher, 1989), yet the genotoxic effects of 
Furosemide are not well characterized 
(Bucher, 1989; Brambilla et al., 2006). Re-
cently, on performing mutagenecity testing 
(Ames test, Comet assay) the effects of deg-
radation products of metoprolol revealed 
positive genotoxicity (Sojic et al., 2012). 
Therefore the genetic-damaging effects of 
these drugs can not be ruled out. Further-
more, the carcinogenicity of cardiovascular 
drugs, including diuretics, beta blockers, 
calcium antagonistics and ACE-inhibitors 
has also been rebated upon (Grossman et 
al., 1999) and requires further research.  
The significantly increased DNA and 
chromosomal damage observed in the PBL 
of CAD patients of the present study is of 
concern as genetic damage is an early indi-
cator of malignancy (Andreassi et al., 2007; 
Manikantan et al., 2010) and can also pro-
mote ageing and neurodegenerative diseas-
es (Farooqui and Farooqui, 2009; Murali-
dhar et al., 2012). Hence there is a need for 
preventive management for these aspects in 
patients with coronary artery disease.  
 
ACKNOWLEDGEMENT 
The authors are very thankful to Dr. 
Michael Fenech (CSIRO Human Nutrition, 
Adelaide, Australia) for providing Cyto-
chalasin-B. The present study was carried 
out with support out of the departmental 
UGC-SAP grant.  
 
 
REFERENCES 
Andreassi MG. Coronary atherosclerosis 
and somatic mutations: an overview of the 
contributive factors for oxidative DNA 
damage. Mutat Res 2003;543:67-86. 
 
Andreassi MG, Botto N, Simi S, Casella M, 
Manfredi S, Lucarelli M et al. Diabetes and 
chronic nitrate therapy as co-determinants 
of somatic DNA damage in patients with 
coronary artery disease. J Mol Med 2005; 
83:279-86. 
 
Andreassi MG, Cioppa A, Manfredi S, 
Palmieri C, Botto N, Picano E. Acute 
chromosomal DNA damage in human lym-
phocytes after radiation exposure in inva-
sive cardiovascular procedures. Eur Heart J 
2007;28: 2195-9. 
 
Anonymous. (2013). People of Punjab more 
prone to heart disease due to their lifestyle. 
Punjab News Line (available at 
www.punjabnewsline.com). 
 
Arca M, Montali A, Valiante S, Campagna 
F, Pigna G, Paoletti V et al. Usefulness of 
atherogenic dyslipidemia for predicting 
cardiovascular risk in patients with angio-
graphically defined coronary artery disease. 
Am J Cardiol 2007;100:1511-6. 
 
Balasubramanyam M, Adaikalakoteswari 
A, Sameermahmood Z, Mohan V. Bio-
markers of oxidative stress: methods and 
measures of oxidative DNA damage 
(COMET assay) and telomere shortening. 
Methods Mol Biol 2010;610:245-61. 
 
Bhat MA, Mahajan N, Gandhi G. Oxidative 
stress status in coronary artery disease pa-
tients. IJLBPR 2012;1:236-43. 
 
Botto N, Rizza A, Colombo MG, Mazzone 
AM, Manfredi S, Masetti S et al. Evidence 
for DNA damage in patients with coronary 
artery disease. Mutat Res 2001;493:23–30. 
 
Brambilla G, Martelli A. Genotoxicity and 
carcinogenicity studies of antihypertensive 
agents. Mutat Res Rev 2006;612:115-49. 
 
Bucher JR. Toxicology and carcinogenesis 
studies of furosemide (CAS No.54-31-9) in 
F344/N rats and B6C3F1 mice (feed stud-
ies). Natl Toxicol Program Tech Rep Ser 
1989;356:1-190. 
 
Chisolm GM, Steinberg D. The oxidative 
modification hypothesis of atherogenesis: 
An overview. Free Radic Biol Med 2000; 
28:1815-26. 
EXCLI Journal 2013;12:872-884 – ISSN 1611-2156 
Received: August 08, 2013, accepted: September 12, 2013, published: October 08, 2013 
 
 
882 
Chobanian AV, Bakris GL, Black HR 
Cushman WC, Green LA, Izzo JL Jr et al. 
The seventh report of the joint national 
committee on prevention, detection, evalua-
tion, and treatment of high blood pressure: 
the JNC 7 report. JAMA 2003;289:2560-
72. 
 
Demirbag R, Yilmaz R, Gur M, Kocyigit A, 
Celik H, Guzel S et al. Lymphocyte DNA 
damage in patients with acute coronary 
syndrome and its relationship with severity 
of acute coronary syndrome. Mutat Res 
2005;578:298–307. 
 
Eastmond DA, Tucker JD. Identification of 
aneuploidy inducing agents using cytokine-
sis–blocked human lymphocytes and an anti 
kinetochore antibody. Environ Mol Mut 
1989;13:34–43. 
 
Farooqui T, Farooqui AA. Aging: an im-
portant factor for the pathogenesis of neu-
rodegenerative diseases. Mech Ageing Dev 
2009;130:203-15. 
 
Fenech M. The in vitro micronucleus tech-
nique. Mutat Res 2000;455:81–95. 
 
Fenech M. Biomarkers of genetic damage 
for cancer epidemiology. Toxicology 2002; 
181–182:411–6. 
 
Fenech M. Cytokinesis-block micronucleus 
cytome assay. Nat Protoc 2007;2:1084–
104. 
 
Gray K, Bennett M. Role of DNA damage 
in atherosclerosis - bystander or partici-
pant? Biochem Pharmacol 2011;82:693-
700. 
 
Grossman E, Messerli FH, Goldbourt U. 
Carcinogenicity of cardiovascular drugs. 
Curr Hypertens Rep 1999;1:212-8. 
 
Hedge ML, Mantha AK, Hazara TK, Bha-
kat KK, Mitra S, Szczensy B. Oxidative 
genome damage and its repair: implications 
in aging and neurodegenerative diseases. 
Mech Ageing Dev 2012;133:157-68. 
 
Ishidate M Jr. Application of chromosomal 
aberration tests in vitro to the primary 
screening for chemicals with carcinogenic 
and/or genetic hazards. Test Courts Cancer-
og Quo Vadis 1983;57-79. 
 
Jameela X, Subramanyam S, Sadasivan G. 
Clastogenic effects of furosemide on human 
leukocytes in culture. Mutat Res 1979;66: 
69–74. 
 
Kasap S, Gonenc A, Sener DE, Hisar I. Se-
rum cardiac markers in patients with acute 
myocardial infarction: oxidative stress, C- 
reactive protein and N-terminal probrain N. 
antiuretic peptide. J Clin Biochem Nutr 
2007;41:50-7. 
 
Kawachi T, Yahagi T, Kada T, Tazima Y, 
Ishidate M, Sasaki M. et al. Cooperative 
programme on short-term assays for car-
cinogenicity in Japan. IARC Sci Publ 1980; 
27:323-30. 
 
Kirkendall WM, Feinleib M, Freis ED, 
Mark AL. Recommendations for human 
blood pressure determination by sphygmo-
manometers. Subcommittee of the AHA 
Postgraduate Education Committee. Stroke 
1981;12:555A-64A. 
 
Kumar N, Shekhar C, Kumar P, Kundu AS. 
Kuppuswamy’s socioeconomic status scale-
updating for 2007. Indian J Pediatr 2007; 
12:1131-2. 
 
Logacheva IV, Leshchinskii LA, Romano-
va ZD, Gaisin AP, Perevalov AP, Karbas-
nikova GV. Use of antioxidants and trimet-
azidine in preparations of patients with is-
chemic heart disease for coronary angi-
ography. Klin Med (Mosk) 2001;79:30-3. 
 
EXCLI Journal 2013;12:872-884 – ISSN 1611-2156 
Received: August 08, 2013, accepted: September 12, 2013, published: October 08, 2013 
 
 
883 
Mahmoudi M, Mercer J, Bennett M. DNA 
damage and repair in atherosclerosis. Car-
diovasc Res 2006;71:259-68. 
 
Manikantan P, Balachandar V, Sasikala K, 
Mohanadevi S. Lymphocyte DNA damage 
in chewing tobacco users of Coimbatore 
Tamilnadu by using comet assay. J Hum 
Ecol 2010;31:53-8. 
 
Martinet W, Knaapen MW, De Meyer GR, 
Herman AG, Kockx MM. Elevated levels 
of oxidative DNA damage and DNA repair 
enzymes in human atherosclerotic plaques. 
Circulation 2002;106:927–32. 
 
McCann J, Choi E, Yamasaki E, Ames BN. 
Detection of carcinogens as mutagens in 
Salmonella/microsome test: Assay of 300 
chemicals. Proc Natl Acad Sci USA 1975; 
72:5135-9. 
 
Mondal SC, Tripathi DN, Vikram A, Rama-
rao P, Jena GB. Furosemide-induced geno-
toxicity and cytotoxicity in the hepatocytes, 
but weak genotoxicity in the bone marrow 
cells of mice. Fund Clin Pharmacol 2012; 
26:383-92. 
 
Moorhead PS, Nowell PC, Mellman WJ, 
Battips DM, Hungerford DA. Chromosome 
preparations of leucocytes cultured from 
human peripheral blood. Exp Cell Res 
1960;20:613-6. 
 
Nadin SB, Vargas-Roig LM, Ciocca DR. A 
silver staining method for single-cell gel as-
say. J Histochem Cytochem 2001;49:1183-
6. 
 
Nojiri S, Daida H, Mokuno H, Iwama Y, 
Mae K, Ushio F et al. Association of serum 
antioxidant capacity with coronary artery 
disease in middle-aged men. Jpn Heart J 
2001;42:677-90. 
 
Norman A, Cochran ST, Sayre JW. Meta-
analysis of increases in micronuclei in pe-
ripheral blood lymphocytes after angio-
graphy or excretory urography. Radiat Res 
2001;155:740–3. 
 
Pérusse L, Rice T, Bouchard C, Vogler GP, 
Rao DC. Cardiovascular risk factors in a 
French-Canadian population: resolution of 
genetic and familial environmental effects 
on blood pressure by using extensive in-
formation on environmental correlates. Am 
J Hum Genet 1989;45:240-251. 
 
Rajesh KG, Surekha RH, Mrudhula SK, 
Prasad Y, Sanjib KS, Prathiba N. Oxidative 
and nitrosative stress in association with 
DNA damage in coronary heart disease. 
Singapore Med J 2011;52:283-8. 
 
Ramakrishnan V, Kumar SG, Thiyagarajan 
G, Madhusudhanan N, Vincent S. Cytoki-
nesis-block micronucleus (CBMN) assay to 
identify DNA damage in patients with cor-
onary artery disease. Int J Med Res 2011;1: 
111-7. 
 
Singh NP, McCoy MT, Tice RR, Schneider 
EL. A simple technique for quantification 
of low levels of DNA damage in individual 
cells. Exp Cell Res 1998;175:184-91. 
 
Snehalatha C, Vishwanathan V, Rama-
chandran A. Cutoff values for normal an-
thropometric variables in asian Indian 
adults. Diabetes Care 2003;26:1380-4. 
 
Šojić D, Despotović V, Orčić D, Szabó E, 
Arany E, Armaković S et al. Degradation of 
thiomethoxam and metoprolol by UV, O3 
and UV/O3 hybrid processes: Kinetics, deg-
radation intermediates and toxicity. J Hy-
drol 2012;472-473:314-27. 
 
Stich HF, Rosin MP, Wu CH, Powrie WD. 
The action of transition metals on the geno-
toxicity of simple phenols, phenolic acids 
and cinnamic acids. Cancer Lett 1981;14: 
251-60. 
EXCLI Journal 2013;12:872-884 – ISSN 1611-2156 
Received: August 08, 2013, accepted: September 12, 2013, published: October 08, 2013 
 
 
884 
Strober W. Trypan Blue Exclusion Test of 
Cell Viability. Curr Protoc Immunol 
2001;21:A.3B.1–A.3B.2.  
 
Weiner JS, Lourie JA. Practical human bi-
ology. London: Academic Press, 1981. 
 
WHO (World Health Organization). Diet, 
nutrition and the prevention of chronic dis-
eases. Report of a joint WHO/FAO expert 
consultation. Geneva: WHO, 2003 (Tech-
nical Report Series, No. 916). 
 
WHO (World Health Organization). Ap-
propriate body-mass index for Asian popu-
lations and its implications for policy and 
intervention strategies. Lancet 2004;363: 
157-63. 
 
Yung LM, Leung FP, Yao X, Chen ZY, 
Huang Y. Reactive oxygen species in vas-
cular wall. Cardiovasc Hematol Disord 
Drug Targets 2006;6:1-19. 
 
Zaman AG, Helft G, Worthley SG, 
Badimon JJ. The role of plaque rupture and 
thrombosis in coronary artery disease. Ath-
erosclerosis 2000;149:251–66. 
